Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.
about
Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancerIs human fecundity changing? A discussion of research and data gaps precluding us from having an answer.Municipal distribution of ovarian cancer mortality in Spain.Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Trends in gynecologic cancer mortality in East Asian regions.Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.Incessant ovulation and ovarian cancer - a hypothesis re-visitedRapid reduction in breast cancer mortality with inorganic arsenic in drinking waterKnockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cisSurvival of patients with ovarian cancer in central and northern Denmark, 1998-2009.Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysisBreastfeeding and maternal health outcomes: a systematic review and meta-analysis.A tale of two time periods: ovarian cancer trends in Ontario.Breast and gynecological cancers in Croatia, 1988-2008.MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity.Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.Role of Neoadjuvant Chemotherapy (NACT) Followed by Surgical Cytoreduction in Advanced Epithelial Ovarian CancerClear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic reviewIn utero exposure to low doses of environmental pollutants disrupts fetal ovarian development in sheep.Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management.Future directions in the management of epithelial ovarian cancer.Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.Incidence and survival rates of ovarian cancer in low-income women in Sudan.Epidemiology of ovarian cancer: a review.Global trends and predictions in ovarian cancer mortality.Ovarian and tubal cancer in Denmark: an update on incidence and survival.Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975.GPER-1 acts as a tumor suppressor in ovarian cancer.Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study.Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.Temporal trends in ovarian cancer: incidence and mortality across Europe.Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study.Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: a population-based study from 1983 to 2007 in Niigata.Breastfeeding and the risk of ovarian cancer: a meta-analysis.Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma.High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy.
P2860
Q30656824-E6749356-7B48-44F1-B191-691601FAE2C3Q31157880-4524F406-3231-4CCD-8E05-26A738D4F2A8Q33369216-AED26142-B9D1-4E40-A80B-C9334298413DQ33723561-93A18328-7BE2-4E02-B260-D0448C721618Q33917307-F8BCD94A-BCA6-419A-95A8-DB191128F697Q33921008-828AC680-7B90-4D96-932C-49EA32D531C6Q34416449-11C734EE-862C-4E61-8241-934ED47644C8Q34866709-6F223755-CC5D-4BEC-831B-EBA60CFAE33EQ35084936-2BAF4AE7-ED7A-4D9A-9271-D8ED55C4FEB9Q35131268-A06445E2-96BE-4537-863B-8D6269FB2810Q35287686-02D9265C-C650-4A9E-A385-49BECF2BC8DDQ35690911-D9DCCA6A-1CD1-41AF-89D7-EFAF88F5AEA5Q35840396-4CDD855A-0B2E-4B3E-9AEA-30D348E4256FQ35929355-97BB9B90-2611-4823-8215-34B3D70D57DBQ36105442-EF2A65BE-FEFC-4A3E-ABBD-CA2017DBD1B0Q36461591-949DE4B2-62AA-49ED-A6B9-DC33A4A1FD21Q36478980-49C0D6DC-EE35-48A3-B540-FD4C32641664Q36547025-CF4EA8BD-ECCE-4CB1-A4D2-2FA9E5B01FE9Q36692536-BD3F4E6F-10E1-449E-972D-80534AC20789Q36758685-D9CADE62-60CE-4951-BF99-1C221034E246Q37179400-E2F25277-33EE-4AD7-896E-6FCE69BA43F3Q37249302-C076F0FE-A457-4D64-95EA-CFB00863295AQ37582038-ED71E12E-AACA-4870-88EF-D5371ED51097Q37720438-0441B66E-5696-411C-8546-4AE8446B7100Q39420632-67D69F3D-B66B-4C15-91F1-AC9DC99DD9BDQ39563666-7350BE68-F9C8-450A-8C1C-4B4E216D567AQ39924415-65FF52C1-1BAA-4AC1-960C-93D0F2CB81D4Q41889998-A8896762-1561-4A50-B797-5D7C8A03C7BEQ42150435-3356A82C-9F61-42F7-8FD8-5F5B76C30A40Q44727753-47E41FBF-11EA-405F-88B2-DB4DD253710EQ46117758-BE8E761D-AADF-4352-88DC-88069391BC27Q46185387-DE3C58D9-A8EC-4703-8C1C-55BBA475E098Q50557183-803D80D2-42B3-4D14-BDF4-EC808CDF5A57Q51356182-D90E2A4C-527A-4CF1-9AD7-41A21C93AA4AQ53150317-C459AB26-3AFB-4F0D-A7CB-87A3E5263732Q54705314-D102F785-4DAC-4C21-ABD0-813FC564FB20Q55017240-0A7A86CB-3F36-4020-9C68-00DBBC4CE3BF
P2860
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Ovarian cancer in Europe: Cros ...... ty in 28 countries, 1953-2000.
@en
type
label
Ovarian cancer in Europe: Cros ...... ty in 28 countries, 1953-2000.
@en
prefLabel
Ovarian cancer in Europe: Cros ...... ty in 28 countries, 1953-2000.
@en
P50
P356
P1476
Ovarian cancer in Europe: Cros ...... ity in 28 countries, 1953-2000
@en
P2093
Anja Helena Loos
P2860
P304
P356
10.1002/IJC.20649
P577
2005-03-01T00:00:00Z